Box score
CASI Pharmaceuticals, Inc.
Reported $15M sold in a new Form D filed July 15, 2024 (Beijing, outside the US).
- Biggest raise
- $15M filed Jul 15, 2024
- League
- Bio & Health Pharmaceuticals
- Based in
- Beijing, outside the US
- Season rank
- #269 of 1,389 in the Bio & Health League; #1337 of 12,443 overall (2024)
- Incorporated
- 2023
- Entity
- Other
Form D filings since 2024 5
| Filed | Form | Sold | Offering | Filing |
|---|---|---|---|---|
| 2026-04-28 | New notice | $5M | $5M | SEC |
| 2026-02-26 | New notice | $5M | $5M | SEC |
| 2026-01-28 | New notice | $5M | $5M | SEC |
| 2026-01-28 | New notice | $5M | $5M | SEC |
| 2024-07-15 | New notice | $15M | $15M | SEC |
Amounts are cumulative for each offering as of the filing date, so an amendment can repeat or update an earlier figure; filings are not added together. CIK 1962738.
Similar raises, 2024
| # | Company | League | Raised |
|---|---|---|---|
| 1 | Spry Therapeutics Inc. rookie | Bio & Health | $15M |
| 2 | Medicenna Therapeutics Corp. | Bio & Health | $14.6M |
| 3 | PolyPid Ltd. | Bio & Health | $14.2M |
| 4 | Chemomab Therapeutics Ltd. | Bio & Health | $10M |
| 5 | RedHill Biopharma Ltd. | Bio & Health | $10M |
| 6 | Fertilidad Integral Ltd. | Bio & Health | $10M |